5 unchanged sentences
We have never declared or paid cash dividends on our common stock.
−Removed: We do not anticipate paying any cash dividends on our capital stock in the foreseeable future.
−Removed: We currently intend to retain all available funds and any future earnings to fund the development and growth of our business.
+Added: We do not anticipate paying any cash dividends on our common stock in the foreseeable future.
+Added: Our shares of Series A convertible preferred stock (the “PIPE Shares”), accrue dividends at 6.50% per year on a cumulative basis, payable in cash or in-kind, and will also participate, on a pro-rata basis, in any dividends that may be declared with respect to our common stock.
+Added: We currently intend to retain all remaining available funds and any future earnings to fund the development and growth of our business.
Recent Sales of Unregistered Securities
+Added: On November 19, 2021, we issued and sold to Ampersand 2020 Limited Partnership, an affiliate of Ampersand Capital Partners (the “PIPE Investor”), a related party, and the PIPE Investor purchased, 25,000 PIPE Shares, for a purchase price of $1,000 per share and an aggregate purchase price of $25.0 million, in a private placement issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D promulgated thereunder.
Issuer Purchases of Equity Securities
2 unchanged sentences
The stock price performance in the graph below is not necessarily indicative of future price performance.
−Removed: Selected Financial Data
−Removed: The following table sets forth selected financial data as of and for the five years ended December 31, 2020.
−Removed: The information has been derived from our audited consolidated financial statements for each of the years ended December 31, 2020, 2019, 2018, 2017, and 2016.
−Removed: The data presented below should be read in conjunction with our consolidated financial statements, the notes to our consolidated financial statements, and “Item 7.
−Removed: Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
−Removed: Years Ended December 31,
−Removed: (in thousands, except per share data)
−Removed: Statement of Operations Data:
−Removed: Total operating expenses
−Removed: Operating (loss)/income from continuing operations
−Removed: Benefit/(provision) for income taxes
−Removed: Net (loss)/income from continuing operations
−Removed: Basic and diluted (loss)/income from continuing operations per share:
−Removed: Basic (loss)/income per share from continuing operations
−Removed: Diluted (loss)/income per share from continuing operations
−Removed: Balance Sheet Data:
−Removed: Total Convertible Notes, net of deferred financing costs
−Removed: Non-current debt, net of deferred financing costs and current component
−Removed: Total stockholder's equity
−Removed: (1) On August 6, 2018, our subsidiary, ANI Pharmaceuticals Canada Inc.
−Removed: (“ANI Canada”), acquired all the issued and outstanding equity interests of WellSpring Pharma Services Inc.
−Removed: (“WellSpring”), a Canadian company that performs contract development and manufacturing of pharmaceutical products for a purchase price of $18.0 million, subject to certain customary adjustments.
−Removed: Pursuant to these customary adjustments, the total purchase consideration was $16.7 million.
−Removed: The consideration was paid entirely from cash on hand.
−Removed: (2) The Tax Cuts and Jobs Act was enacted on December 22, 2017.
−Removed: The Tax Cuts and Jobs Act includes a number of changes to existing U.S.
−Removed: tax laws, most notably the reduction of the U.S.
−Removed: corporate income tax rate from 35% to 21%, which began in 2018.
−Removed: Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.
−Removed: As a result, we remeasured our deferred tax assets and deferred tax liabilities to reflect the reduction in the enacted U.S.
−Removed: corporate income tax rate, resulting in a $13.4 million increase in income tax expense for the year ended December 31, 2017.
−Removed: Income Taxes, in the notes to the consolidated financial statements in Part II, Item 8.
−Removed: of this Annual Report on Form 10-K for further information.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.